Prestige Consumer Healthcare (PBH) FY2021 results: revenue $943 million, down 2.0% on the year
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $943 million for fiscal 2021, the year ended 31 March 2021, down 2.0% on the year before. Net income was $165 million, up 15.7%, and diluted earnings per share $3.25. The figures are the company's own, from the 10-K it filed with the SEC on 7 May 2021.
Revenue
$943 million
-2.0% on the year
FY2014FY2021
Operating margin
31.5%
30.2% a year earlier
FY2014FY2021
Net income
$165 million
+15.7% on the year
FY2014FY2021
Diluted EPS
$3.25
+16.9% on the year
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Revenue
943
963
976
-2.0%
Cost of revenue
396
411
420
-3.6%
Gross profit
547
552
556
-0.9%
Gross margin
58.0%
57.3%
56.9%
Operating income
297
291
67.5
+2.1%
Operating margin
31.5%
30.2%
6.9%
Interest expense
82.3
96.2
105
-14.4%
Pre-tax income
204
191
-38.1
+6.8%
Income tax
39.4
48.9
-2.3
-19.3%
Effective tax rate
19.3%
25.6%
n/a
Net income
165
142
-35.8
+15.7%
Net margin
17.5%
14.8%
-3.7%
Diluted EPS
$3.25
$2.78
-$0.69
+16.9%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
236
217
189
+8.5%
Capital expenditure
22.2
14.6
10.5
+52.8%
Free cash flow
213
203
179
+5.3%
Free cash flow margin
22.6%
21.0%
18.3%
Cash from investing
-22.2
-16.6
55.4
Cash from financing
-279
-131
-249
Depreciation and amortisation
30.2
29.0
31.8
+4.0%
Share-based compensation
8.5
7.6
7.4
+11.8%
Buybacks
11.9
56.7
50.0
-79.1%
Diluted shares, weighted
51m
51m
52m
-1.0%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
1,358
1,171
1,096
+16.0%
Debt
1,480
1,730
1,799
-14.5%
Operating lease liabilities
19.7
24.9
0.0
-20.8%
Finance lease liabilities
6.8
4.6
0.0
+47.3%
Other liabilities
565
583
547
-3.1%
Total liabilities and equity
3,429
3,514
3,441
-2.4%
Fixed assets
70.1
56.0
51.2
+25.1%
Goodwill
578
575
579
+0.5%
Intangible assets
2,476
2,479
2,507
-0.1%
Cash and equivalents
32.3
94.8
27.5
-65.9%
Receivables
115
151
149
-23.8%
Inventory
115
116
120
-0.9%
Other assets
43.5
42.0
7.9
+3.4%
Total assets
3,429
3,514
3,441
-2.4%
10-K for the year ended 31 March 2021, filed 7 May 2021: the filing.